YT6-22126-02533

3 vaccinations 12 coded responses 24 check-ins 12 free-text entries 2 call cases

Sex: —
Age at first dose: 66+
ZIP prefix: 197 / DE
Registered: 2021-01-25

Relationship: Self
Race: Black or African American
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-24
Dose 1 — Pfizer-BioNTech
2021-01-25
Registered in v-safe
2021-01-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-26
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-27
Survey response — days 1–6 daily, dose 1
MedDRA: Lethargy — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Extreme lethargy.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-28
Survey response — days 1–6 daily, dose 1
MedDRA: Lethargy — Feeling: Fair

Free text: Lethargy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-01-30
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2021-01-31
Health check-in — day 7, dose 1
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2021-02-07
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 28, dose 1
Feeling: Good

Adult check-in
2021-02-24
Dose 2 — Pfizer-BioNTech
2021-02-27
Survey response — days 1–6 daily, dose 2
MedDRA: Lethargy, Somnolence — Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activities

Free text: Extreme lethargy. Slept for 15 hours sporadically.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-28
Survey response — days 1–6 daily, dose 2
MedDRA: Lethargy — Feeling: Good · Muscle or body aches · Be unable to do your normal daily activities

Free text: Lethargy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-01
Survey response — days 1–6 daily, dose 2
MedDRA: Lethargy — Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activities

Free text: Lethargy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-02
Survey response — days 1–6 daily, dose 2
MedDRA: Fatigue, Sleep disorder — Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activities

Free text: Tiredness and interrupted sleep.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-04
Survey response — day 7, dose 2
MedDRA: Fatigue — Feeling: Good · Muscle or body aches

Free text: Tiredness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-10
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-03-17
Survey response — day 21, dose 2
MedDRA: Fatigue, Myalgia — Feeling: Fair · Be unable to do your normal daily activities

Free text: Extreme fatigueSome muscle aches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-24
Survey response — day 28, dose 2
MedDRA: Blood glucose increased, Blood pressure increased, Lethargy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Extreme lethargyElevated blood glucose levelsElevated blood pressure

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-24
Report sent to call center — day 28, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-31
Survey response — day 35, dose 2
MedDRA: Lethargy — Feeling: Fair · Be unable to do your normal daily activities

Free text: Extreme lethargy-- not very much diminished since last week.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-11
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-05-26
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-25
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-10
Dose 3 — Pfizer-BioNTech
2022-02-24
Survey response — 12 months, dose 2
MedDRA: Gait disturbance, Pain in extremity — Feeling: Good · Be unable to do your normal daily activities

Free text: Pain in calf of right leg which impedes my walking

MedDRA releases: 2024-11 · check-in free text available
2022-03-08
Call successful
Participant prefers to complete VAERS report online
2022-04-10
Health check-in — 6 months, dose 3
Feeling: Fair

Adult check-in
2022-10-10
Survey response — 12 months, dose 3
MedDRA: Eye pain, Lethargy, Office visit, Pain — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Symptoms: This was post-booster shot #3: Extreme lethargy. Pain in left eye and left temple. · Healthcare visit (other): Opthamologist visit

MedDRA releases: 2024-11 · check-in free text available
2022-10-10
Report sent to call center — 12 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2022-10-11
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-24	Pfizer-BioNTech
2	2021-02-24	Pfizer-BioNTech
3	2021-10-10	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-03-24	Successful 2022-03-08	Participant prefers to complete VAERS report online
2022-10-10	Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-27

Systemic reaction (other): Extreme lethargy.

2021-01-28

Systemic reaction (other): Lethargy

Release 4 — days 1–6 daily, dose 2

2021-02-27

Systemic reaction (other): Extreme lethargy. Slept for 15 hours sporadically.

2021-02-28

Systemic reaction (other): Lethargy

2021-03-01

Systemic reaction (other): Lethargy

2021-03-02

Systemic reaction (other): Tiredness and interrupted sleep.

Release 5 — day 7, dose 2

2021-03-04

Systemic reaction (other): Tiredness

Release 5 — day 21, dose 2

2021-03-17

Symptoms: Extreme fatigueSome muscle aches

Release 6 — day 28, dose 2

2021-03-24

Symptoms: Extreme lethargyElevated blood glucose levelsElevated blood pressure

Release 6 — day 35, dose 2

2021-03-31

Symptoms: Extreme lethargy-- not very much diminished since last week.

Release 11 — 12 months, dose 2

2022-02-24

Symptoms: Pain in calf of right leg which impedes my walking

Release 12 — 12 months, dose 3

2022-10-10

Symptoms: This was post-booster shot #3: Extreme lethargy. Pain in left eye and left temple.

Healthcare visit (other): Opthamologist visit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Blood glucose increased	✓	✓	✓
SD	Blood pressure increased	✓	✓	✓
SD	Eye pain	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Gait disturbance	·	·	✓
SD	Lethargy	✓	✓	✓
SD	Myalgia	✓	✓	✓
SD	Pain	·	·	✓
SD	Pain in extremity	·	·	✓
SRO	Fatigue	✓	✓	✓
SRO	Lethargy	✓	✓	✓
SRO	Sleep disorder	✓	✓	✓
SRO	Somnolence	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release